UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048197
Receipt number R000054928
Scientific Title Study of the Prevalence of celiac disease in Asian countries
Date of disclosure of the study information 2022/06/30
Last modified on 2024/01/04 12:22:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of the Prevalence of celiac disease in Asian countries

Acronym

Study of the Prevalence of celiac disease in Asian countries

Scientific Title

Study of the Prevalence of celiac disease in Asian countries

Scientific Title:Acronym

Study of the Prevalence of celiac disease in Asian countries

Region

Japan


Condition

Condition

Celiac disease

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To study the prevalence of celiac disease in Asian countries.

Basic objectives2

Others

Basic objectives -Others

To study HLA in the patients who are seropositive of Celiac disease

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To determine the prevalence of seropositive Celiac disease in patients with IBS.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

patienst with IBS

Key exclusion criteria

DM, IBD, pregnant women, post-surgery

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name Masaaki
Middle name
Last name Higashiyama

Organization

National Defense Medical College

Division name

department of internal medicine

Zip code

359-8513

Address

National Defense Medical College

TEL

0429951609

Email

cln311@ndmc.ac.jp


Public contact

Name of contact person

1st name Ryota
Middle name
Last name Hokari

Organization

National Defense Medical College

Division name

department of internal medicine

Zip code

359-8513

Address

3-2 Namiki tokorozawa

TEL

0429951609

Homepage URL


Email

ryota@ndmc.ac.jp


Sponsor or person

Institute

National Defense Medical College

Institute

Department

Personal name



Funding Source

Organization

National Defense Medical College

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Defense Medical College

Address

National Defense Medical College

Tel

0429951609

Email

ins010@ndmc.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 06 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2021 Year 03 Month 09 Day

Date of IRB

2022 Year 05 Month 19 Day

Anticipated trial start date

2022 Year 05 Month 20 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

multi-center study


Management information

Registered date

2022 Year 06 Month 29 Day

Last modified on

2024 Year 01 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054928


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name